Skip to main content

Table 1 Oligonucleotide primers used in this study

From: Comprehensive evaluation of the safety and immunogenicity of a gene-deleted variant pseudorabies virus attenuated vaccine

Primers

Sequence (5′–3′)

P1F

GGAATTCGGTGGTGGCGCTGATCTCCGACCCG

P1R

CCCAAGCTTAGCAGGCGCGCTTGGGGTCGAGG

P2F

CCCAAGCTTAGACGCACGAGCTGACGCG

P2R

CGACGCGTCGTGTCATCGGGTGCCAGAGCGAGAGCG

P3F

CGGTCGCCACCATGGTGAGCAAG

P3R

GCGGATCTGACGGTTCACTAAACCAGCTC

P4F

CCCAAGCTTTTAGTTATTAATAGTAATCAATTACGGGGTCATTAG

P4R

CCCAAGCTTCTAGAATGCAGTGAAAAAAATGCTTTATTTG

P5F

GGAATTCCGCTCCAGCGGCCGCAGCTGCTCGTCCACCTCGGCCTC

P5R

CCCAAGCTTGGGCGGGCCCTCGACCGCGGGCCCG

P6F

CCCAAGCTTACGGCGACCACATCCGGCAGTGCGTG

P6R

CGACGCGTGCCGAGGCGCACCGCCGCGCGGTAAAAGTAGTACGG

P7F

GCGACGCGCCCAACCTGACGA

P7R

GGCCCCCGAGTTCAGGTACTGGATCC

P8F

TCTGTTCGACACGGACAC

P8R

GGGATGACATACACATGGC

  1. Restriction sites for cloning are underlined and shown in italics and bold.